ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

OPT Opthea Ltd

3.20
-0.02 (-0.62%)
May 24 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Opthea Ltd OPT NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
-0.02 -0.62% 3.20 19:00:00
Open Price Low Price High Price Close Price Previous Close
3.24 3.19 3.33 3.20 3.22
more quote information »

Recent News

Date Time Source Heading
2/14/202405:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/01/202405:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/11/202405:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/27/202305:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/27/202305:00GLOBEOpthea to Receive US$35M Commitment and Additional US$50M..
12/19/202305:00GLOBEOpthea Receives A$8.8 million R&D Tax Incentive
12/01/202304:30GLOBEOpthea to Present at the FLORetina 2023 Congress
11/09/202305:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/09/202304:30GLOBEOpthea to Present at the Jefferies 2023 London Healthcare..
10/30/202304:30GLOBEOpthea to Present at Eyecelerator Forum at the 2023 American..
10/27/202305:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/27/202305:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/27/202304:30GLOBEOpthea Appoints U.S.-Based Leadership with Fred Guerard as..
10/02/202304:30GLOBEOpthea to Participate at the 2023 Euretina Congress
9/07/202305:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/07/202304:30GLOBEOpthea to Present at the H.C. Wainwright 25th Annual Global..
8/28/202305:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/28/202304:30GLOBEOpthea Successfully Completes Institutional Offer and..
8/24/202305:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/01/202305:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/26/202305:00GLOBEOpthea Announces “Sozinibercept” as the Nonproprietary Drug..
7/24/202305:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/24/202305:00GLOBEOpthea to Present at the 2023 Ophthalmology Innovation..
7/13/202305:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/13/202305:00GLOBEOpthea to Feature at the American Society of Retina..
7/10/202305:00GLOBEOpthea Announces Departure of Chief Medical Officer and..
6/08/202305:00GLOBEOpthea Appoints Anshul Thakral as Non-Executive Director of..